Bank Pictet & Cie Europe AG bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 13,780 shares of the exchange traded fund’s stock, valued at approximately $1,680,000.
Several other large investors have also modified their holdings of XBI. Capital A Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $26,000. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at about $32,000. Davis Capital Management purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $35,000. Halbert Hargrove Global Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter worth about $40,000. Finally, Barnes Dennig Private Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $48,000.
SPDR S&P Biotech ETF Stock Up 0.6%
NYSEARCA XBI opened at $128.55 on Thursday. The stock has a market capitalization of $8.59 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09. The firm has a 50-day moving average price of $125.03 and a 200 day moving average price of $117.89.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
